Cargando…
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
BACKGROUND: Soft tissue sarcomas are a heterogeneous and rare group of solid tumors of mesenchymal origin that can arise anywhere in the body. Although surgical resection is the mainstay of treatment for patients with localized disease, disease recurrence is common and 5-year overall survival is poo...
Autores principales: | Keung, Emily Z., Lazar, Alexander J., Torres, Keila E., Wang, Wei-Lien, Cormier, Janice N., Ashleigh Guadagnolo, B., Bishop, Andrew J., Lin, Heather, Hunt, Kelly K., Bird, Justin, Lewis, Valerae O., Patel, Shreyaskumar R., Wargo, Jennifer A., Somaiah, Neeta, Roland, Christina L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154892/ https://www.ncbi.nlm.nih.gov/pubmed/30249211 http://dx.doi.org/10.1186/s12885-018-4829-0 |
Ejemplares similares
-
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
por: May, Caitlin D., et al.
Publicado: (2015) -
The immune landscape of undifferentiated pleomorphic sarcoma
por: Lazcano, Rossana, et al.
Publicado: (2022) -
Overview of systemic therapy options in liposarcoma, with a focus on the activity of selinexor, a selective inhibitor of nuclear export in dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022) -
Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022) -
PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma
por: Parkes, Amanda, et al.
Publicado: (2020)